INCANNEX HEALTHCARE INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.49 USD | -2.35% |
|
+4.18% | -46.34% |
| May. 07 | Incannex Complete Successful Pre-Ind Meeting with the Fda for Cannquit-O for Treatment of Opioid Use Disorder | CI |
| Mar. 05 | Incannex Healthcare Inc. Announces CFO Changes | CI |
Valuation
| Fiscal Period: June | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 7,167 | 4,373 |
| Enterprise Value (EV) 1 | 7,130 | 4,340 |
| P/E ratio | -447 x | -212 x |
| Yield | - | - |
| Capitalization / Revenue | 9,161 x | 4,313 x |
| EV / Revenue | 9,113 x | 4,281 x |
| EV / EBITDA | - | -246 x |
| EV / FCF | -1,568 x | -578 x |
| FCF Yield | -0.06% | -0.17% |
| Price to Book | 201 x | 52 x |
| Nbr of stocks (in thousands) | 320,584 | 396,753 |
| Reference price 2 | 22.36 | 11.02 |
| Announcement Date | 9/19/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: Giugno | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 1.012 | 1.178 | 0.6094 | 1.898 | 0.7824 | 1.014 |
| EBITDA 1 | -2.942 | -2.647 | -3.652 | - | - | -17.68 |
| EBIT 1 | -2.996 | -2.689 | -3.694 | -6.939 | -11.35 | -17.71 |
| Operating Margin | -296.03% | -228.15% | -606.16% | -365.67% | -1,450.78% | -1,746.78% |
| Earnings before Tax (EBT) 1 | -3.211 | -2.87 | -3.929 | -8.164 | -14.9 | -19.98 |
| Net income 1 | -2.948 | -2.718 | -4.698 | -8.164 | -14.9 | -19.98 |
| Net margin | -291.24% | -230.67% | -770.83% | -430.21% | -1,904.94% | -1,970.61% |
| EPS 2 | -0.0520 | -0.0244 | -0.0275 | -0.0334 | -0.0500 | -0.0520 |
| Free Cash Flow 1 | -1.664 | -1.668 | -1.885 | -3.054 | -4.548 | -7.503 |
| FCF margin | -164.35% | -141.58% | -309.26% | -160.96% | -581.25% | -739.99% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 9/2/18 | 8/30/19 | 8/14/20 | 8/30/21 | 9/19/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: June | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 0.03 | 0.03 | 3.6 | 9.12 | 37.5 | 32.6 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | -1.66 | -1.67 | -1.88 | -3.05 | -4.55 | -7.5 |
| ROE (net income / shareholders' equity) | 1,068% | 679% | -286% | -139% | -67.1% | -33.3% |
| ROA (Net income/ Total Assets) | -219% | -274% | -97.1% | -63.9% | -30.1% | -17.5% |
| Assets 1 | 1.344 | 0.9915 | 4.836 | 12.77 | 49.59 | 114.1 |
| Book Value Per Share 2 | -0.0100 | -0 | 0.0200 | 0.0300 | 0.1100 | 0.2100 |
| Cash Flow per Share 2 | 0 | 0 | 0.0200 | 0.0300 | 0.1200 | 0.0800 |
| Capex 1 | 0.05 | 0.02 | - | - | - | 0.48 |
| Capex / Sales | 4.7% | 2.07% | - | - | - | 47.03% |
| Announcement Date | 9/2/18 | 8/30/19 | 8/14/20 | 8/30/21 | 9/19/22 | 8/30/23 |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -46.34% | 40.48M | |
| +40.09% | 6.3B | |
| -16.34% | 4.53B | |
| -7.11% | 3.29B | |
| +5.14% | 3.2B | |
| -0.18% | 2.63B | |
| +47.93% | 1.97B | |
| -7.15% | 1.74B | |
| +0.67% | 1.69B | |
| -8.73% | 1.64B |
- Stock Market
- Equities
- IXHL Stock
- Financials Incannex Healthcare Inc.
